Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancers

Rebouissou et al. recently provided preclinical evidence that a subset of patients with muscle-invasive bladder cancer might benefit from anti-epidermal growth factor receptor (EGFR) therapy and reported diagnostic tools for identifying these patients in the clinical setting. This work also identifi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mol Cell Oncol
Hauptverfasser: Lebret, Thierry, Neuzillet, Yann, Houede, Nadine, Rebouissou, Sandra, Bernard-Pierrot, Isabelle, De Reynies, Aurélien, Benhamou, Simone, Allory, Yves, Radvanyi, François
Format: Artigo
Sprache:Inglês
Veröffentlicht: Taylor & Francis 2015
Schlagworte:
Author's View
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4905367/
https://ncbi.nlm.nih.gov/pubmed/27308521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2014.999507
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge